Effects of glycaemic variability on cardiac remodelling after reperfused myocardial infarction: Evaluation of streptozotocin-induced diabetic Wistar rats using cardiac magnetic resonance imaging

Diabetes and Metabolism

Volumn 42, Issue 5, 2016, Pages 342-350

  Joubert, M ^a,f   Hardouin, J ^a,f   Legallois, D ^a,f   Blanchart, K ^a,f   Elie, N ^b   Nowoczyn, M ^a,f   Croisille, P ^c,d   Coulbault, L ^a,f   Bor Angelier, C ^e   Allouche, S ^a,f   Manrique, A ^a,f  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b Biology and Innovative Therapeutics for Ovarian Cancers group   (France)

^c UNIVERSITÉ JEAN MONNET   (France)

^d UNIVERSITÉ DE LYON   (France)

^e F Baclesse Comprehensive Cancer Center   (France)

^f NORMANDIE UNIVERSITÉ   (France)

Author keywords

Animals; Cardiac magnetic resonance imaging; Diabetes; Glycaemic variability; Myocardial ischaemia reperfusion; Myocardial oedema

Indexed keywords

GLUCOSE; TROPONIN; GLUCOSE BLOOD LEVEL; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CARDIOVASCULAR MAGNETIC RESONANCE; COMPARATIVE STUDY; EXPERIMENTAL MYOCARDIAL ISCHEMIA; GLUCOSE BLOOD LEVEL; GLYCEMIC VARIABILITY; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE FIBROSIS; HEART MUSCLE REPERFUSION; MALE; NONHUMAN; RAT; SHAM PROCEDURE; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANALYSIS; ANIMAL; CARDIAC IMAGING; DIAGNOSTIC IMAGING; EXPERIMENTAL DIABETES MELLITUS; HEART MUSCLE ISCHEMIA; HEART VENTRICLE REMODELING; HYPERGLYCEMIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZATION; WISTAR RAT;

ANIMALS; BLOOD GLUCOSE; CARDIAC IMAGING TECHNIQUES; DIABETES MELLITUS, EXPERIMENTAL; HYPERGLYCEMIA; MAGNETIC RESONANCE IMAGING; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; RANDOM ALLOCATION; RATS; RATS, WISTAR; STREPTOZOCIN; VENTRICULAR REMODELING;

EID: 84960173050     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2016.02.002     Document Type: Article

References (44)

1. [1] Whiting, D.R., Guariguata, L., Weil, C., Shaw, J., IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94 (2011), 311–321.
2. [2] Aronson, D., Rayfield, E.J., Chesebro, J.H., Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction. Ann Intern Med 126 (1997), 296–306.
3. [3] Aronson, D., Edelman, E.R., Coronary artery disease and diabetes mellitus. Cardiol Clin 32 (2014), 439–455.
4. [4] Kosiborod, M., Inzucchi, S.E., Krumholz, H.M., Xiao, L., Jones, P.G., Fiske, S., et al. Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation 117 (2008), 1018–1027.
5. [5] Lin, C.C., Li, C.I., Yang, S.Y., Liu, C.S., Chen, C.C., Fuh, M.M., et al. Variation of fasting plasma glucose: a predictor of mortality in patients with type 2 diabetes. Am J Med 125 (2012), 416e9–416e18.
6. [6] Muggeo, M., Verlato, G., Bonora, E., Zoppini, G., Corbellini, M., de Marco, R., Long-term instability of fasting plasma glucose, a novel predictor of cardiovascular mortality in elderly patients with non-insulin-dependent diabetes mellitus: the Verona Diabetes Study. Circulation 96 (1997), 1750–1754.
7. [7] Krinsley, J.S., Egi, M., Kiss, A., Devendra, A.N., Schuetz, P., Maurer, P.M., et al. Diabetic status and the relation of the three domains of glycaemic control to mortality in critically ill patients: an international multicenter cohort study. Crit Care, 17, 2013, R37.
8. [8] Sutton, M.G., Sharpe, N., Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 101 (2000), 2981–2988.
9. [9] Ceriello, A., Kilpatrick, E.S., Glycaemic variability: both sides of the story. Diabetes Care 36 (2013), S272–S275.
10. [10] Akki, A., Gupta, A., Weiss, R.G., Magnetic resonance imaging and spectroscopy of the murine cardiovascular system. Am J Physiol Heart Circ Physiol 304 (2013), H633–H648.
11. [11] Epstein, F.H., MR in mouse models of cardiac disease. NMR Biomed 20 (2007), 238–255.
12. [12] Franco, F., Thomas, G.D., Giroir, B., Bryant, D., Bullock, M.C., Chwialkowski, M.C., et al. Magnetic resonance imaging and invasive evaluation of development of heart failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation 99 (1999), 448–454.
13. [13] Epstein, F.H., Yang, Z., Gilson, W.D., Berr, S.S., Kramer, C.M., French, B.A., MR tagging early after myocardial infarction in mice demonstrates contractile dysfunction in adjacent and remote regions. Magn Reson Med 48 (2002), 399–403.
14. [14] García-Dorado, D., Oliveras, J., Gili, J., Sanz, E., Pérez-Villa, F., Barrabés, J., et al. Analysis of myocardial oedema by magnetic resonance imaging early after coronary artery occlusion with or without reperfusion. Cardiovasc Res 27 (1993), 1462–1469.
15. [15] Arai, A.E., Leung, S., Kellman, P., Controversies in cardiovascular MR imaging: reasons why imaging myocardial T2 has clinical and pathophysiologic value in acute myocardial infarction. Radiology 265 (2012), 23–32.
16. [16] Lebeau, R., Serri, K., Morice, M.C., Hovasse, T., Unterseeh, T., Piéchaud, J.F., et al. Assessment of left ventricular ejection fraction using the wall motion score index in cardiac magnetic resonance imaging. Arch Cardiovasc Dis 105 (2012), 91–98.
17. [17] Goode, A., Gilbert, B., Harkes, J., Jukic, D., Satyanarayanan, M., OpenSlide: a vendor-neutral software foundation for digital pathology. J Pathol Inform, 4, 2013, 27.
18. [18] Di Filippo, C., Marfella, R., Cuzzocrea, S., Piegari, E., Petronella, P., Giugliano, D., et al. Hyperglycaemia in streptozotocin-induced diabetic rat increases infarct size associated with low levels of myocardial HO-1 during ischemia/reperfusion. Diabetes 54 (2005), 803–810.
19. [19] Marfella, R., D'Amico, M., Di Filippo, C., Piegari, E., Nappo, F., Esposito, K., et al. Myocardial infarction in diabetic rats: role of hyperglycaemia on infarct size and early expression of hypoxia-inducible factor 1. Diabetologia 45 (2002), 1172–1181.
20. [20] Shiomi, T., Tsutsui, H., Ikeuchi, M., Matsusaka, H., Hayashidani, S., Suematsu, N., et al. Streptozotocin-induced hyperglycaemia exacerbates left ventricular remodeling and failure after experimental myocardial infarction. J Am Coll Cardiol 42 (2003), 165–172.
21. [21] Bugger, H., Abel, E., Rodent models of diabetic cardiomyopathy. Dis Model Mech 2 (2009), 454–466.
22. [22] Richardson, J.D., Bertaso, A.G., Frost, L., Psaltis, P.J., Carbone, A., Koschade, B., et al. Cardiac magnetic resonance, transthoracic and transoesophageal echocardiography: a comparison of in vivo assessment of ventricular function in rats. Lab Anim 47 (2013), 291–300.
23. [23] Nagarajan, V., Gopalan, V., Kaneko, M., Angeli, V., Gluckman, P., Richards, A.M., et al. Cardiac function and lipid distribution in rats fed a high-fat diet: in vivo magnetic resonance imaging and spectroscopy. Am J Physiol Heart Circ Physiol 304 (2013), H1495–H1504.
24. [24] de Jong, S., Zwanenburg, J.J., Visser, F., der Nagel, R., van Rijen, H.V., Vos, M.A., et al. Direct detection of myocardial fibrosis by MRI. J Mol Cell Cardiol 51 (2011), 974–979.
25. [25] García-Dorado D1, Oliveras, J., Gili, J., Sanz, E., Pérez-Villa, F., Barrabés, J., et al. Analysis of myocardial oedema by magnetic resonance imaging early after coronary artery occlusion with or without reperfusion. Cardiovasc Res 27 (1993), 1462–1469.
26. [26] Higgins, C.B., Herfkens, R., Lipton, M.J., Sievers, R., Sheldon, P., Kaufman, L., et al. Nuclear magnetic resonance imaging of acute myocardial infarction in dogs: alterations in magnetic relaxation times. Am J Cardiol 52 (1983), 184–188.
27. [27] Verma, S., Fedak, P., Weisel, R., Butany, J., Rao, V., Maitland, A., et al. Fundamentals of reperfusion injury for the clinical cardiologist. Circulation 105 (2002), 2332–2336.
28. [28] Abdel-Aty, H., Zagrosek, A., Schulz-Menger, J., Taylor, A.J., Messroghli, D., Kumar, A., et al. Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation 109 (2004), 2411–2416.
29. [29] Manrique, A., Gerbaud, E., Derumeaux, G., Cribier, A., Bertrand, D., Lebon, A., et al. Cardiac magnetic resonance demonstrates myocardial edema in remote tissue early after reperfused myocardial infarction. Arch Cardiovasc Dis 102 (2009), 633–639.
30. [30] Croisille, P., Kim, H.W., Kim, R.J., Controversies in cardiovascular MR imaging: T2-weighted imaging should not be used to delineate the area at risk in ischemic myocardial injury. Radiology 265 (2012), 12–22.
31. [31] Mewton, N., Rapacchi, S., Augeul, L., Ferrera, R., Loufouat, J., Boussel, L., et al. Determination of the myocardial area at risk with pre- versus post-reperfusion imaging techniques in the pig model. Basic Res Cardiol 106 (2011), 1247–1257.
32. [32] Fernández-Jiménez, R., Sánchez-González, J., Agüero, J., García-Prieto, J., López-Martín, G.J., García-Ruiz, J.M., et al. Myocardial edema after ischemia/reperfusion is not stable and follows a bimodal pattern: imaging and histological tissue characterization. J Am Coll Cardiol 65 (2015), 315–323.
33. [33] Schulz-Menger J1, Gross, M., Messroghli, D., Uhlich, F., Dietz, R., Friedrich, M.G., Cardiovascular magnetic resonance of acute myocardial infarction at a very early stage. J Am Coll Cardiol 42 (2003), 513–518.
34. [34] Horvath, E.M., Benko, R., Kiss, L., Murányi, M., Pék, T., Fekete, K., et al. Rapid ‘glycaemic swings’ induce nitrosative stress, activate poly(ADP-ribose) polymerase and impair endothelial function in a rat model of diabetes mellitus. Diabetologia 52 (2009), 952–961.
35. [35] Biscetti, F., Pitocco, D., Straface, G., Zaccardi, F., de Cristofaro, R., Rizzo, P., et al. Glycaemic variability affects ischaemia-induced angiogenesis in diabetic mice. Clin Sci (Lond) 121 (2011), 555–564.
36. [36] Quagliaro, L., Piconi, L., Assaloni, R., Martinelli, L., Motz, E., Ceriello, A., Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes 52 (2003), 2795–2804.
37. [37] Piconi, L., Quagliaro, L., Assaloni, R., Da Ros, R., Maier, A., Zuodar, G., et al. Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction. Diabetes Metab Res Rev 22 (2006), 198–203.
38. [38] Sun, L.Q., Chen, Y.Y., Wang, X., Li, X.J., Xue, B., Qu, L., et al. The protective effect of alpha lipoic acid on Schwann cells exposed to constant or intermittent high glucose. Biochem Pharmacol 84 (2012), 961–973.
39. [39] Sun, D., Huang, J., Zhang, Z., Gao, H., Li, J., Shen, M., et al. Luteolin limits infarct size and improves cardiac function after myocardium ischemia/reperfusion injury in diabetic rats. PLoS One, 7, 2012, e33491.
40. [40] Ho, Y.J., Lee, A.S., Chen, W.P., Chang, W.L., Tsai, Y.K., Chiu, H.L., et al. Caffeic acid phenethyl amide ameliorates ischemia/reperfusion injury and cardiac dysfunction in streptozotocin-induced diabetic rats. Cardiovasc Diabetol, 13, 2014, 98.
41. [41] Gohbara, M., Iwahashi, N., Kataoka, S., Hayakawa, Y., Sakamaki, K., Akiyama, E., et al. Glycaemic variability determined by continuous glucose monitoring system predicts left ventricular remodeling in patients with a first ST-segment elevation myocardial infarction. Circ J 79 (2015), 1092–1099.
42. [42] Litwin, S.E., Raya, T.E., Anderson, P.G., Daugherty, S., Goldman, S., Abnormal cardiac function in the streptozotocin-diabetic rat: changes in active and passive properties of the left ventricle. J Clin Invest 86 (1990), 481–488.
43. [43] McGrath, G.M., McNeill, J.H., Cardiac ultrastructural changes in streptozotocin-induced diabetic rats: effects of insulin treatment. Can J Cardiol 2 (1986), 164–169.
44. [44] Nordbeck, P., Bönhof, L., Hiller, K.H., Voll, S., Arias-Loza, P., Seidlmayer, L., et al. Impact of thoracic surgery on cardiac morphology and function in small animal models of heart disease: a cardiac MRI study in rats. PLoS One, 8, 2013, e68275.